Marie Amalric, Ph.D. - Publications

Affiliations: 
2012-2017 CEA-INSERM Cognitive Neuroimaging Unit 
 2018-2020 Carnegie Mellon University, Pittsburgh, PA 
 2020-2022 Harvard University, Cambridge, MA, United States 
 2022- University of Trento, CIMeC 
Area:
mathematical cognition

14/97 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Amalric M, Cantlon JF. Entropy, complexity, and maturity in children's neural responses to naturalistic video lessons. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 163: 14-25. PMID 37037065 DOI: 10.1016/j.cortex.2023.02.008  0.604
2023 Amalric M, Roveyaz P, Dehaene S. Evaluating the impact of short educational videos on the cortical networks for mathematics. Proceedings of the National Academy of Sciences of the United States of America. 120: e2213430120. PMID 36730198 DOI: 10.1073/pnas.2213430120  0.476
2022 Amalric M, Cantlon JF. Common Neural Functions during Children's Learning from Naturalistic and Controlled Mathematics Paradigms. Journal of Cognitive Neuroscience. 1-19. PMID 35303098 DOI: 10.1162/jocn_a_01848  0.617
2021 Al Roumi F, Marti S, Wang L, Amalric M, Dehaene S. Mental compression of spatial sequences in human working memory using numerical and geometrical primitives. Neuron. PMID 34228961 DOI: 10.1016/j.neuron.2021.06.009  0.666
2021 Sablé-Meyer M, Fagot J, Caparos S, van Kerkoerle T, Amalric M, Dehaene S. Sensitivity to geometric shape regularity in humans and baboons: A putative signature of human singularity. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33846254 DOI: 10.1073/pnas.2023123118  0.491
2019 Dillon MR, Duyck M, Dehaene S, Amalric M, Izard V. Geometric categories in cognition. Journal of Experimental Psychology. Human Perception and Performance. PMID 31219284 DOI: 10.1037/Xhp0000663  0.621
2019 Amalric M, Dehaene S. A distinct cortical network for mathematical knowledge in the human brain. Neuroimage. 189: 19-31. PMID 30611876 DOI: 10.1016/J.Neuroimage.2019.01.001  0.592
2018 Le Guen Y, Amalric M, Pinel P, Pallier C, Frouin V. Shared genetic aetiology between cognitive performance and brain activations in language and math tasks. Scientific Reports. 8: 17624. PMID 30514932 DOI: 10.1038/S41598-018-35665-0  0.406
2018 Wang L, Amalric M, Fang W, Jiang X, Pallier C, Figueira S, Sigman M, Dehaene S. Representation of spatial sequences using nested rules in human prefrontal cortex. Neuroimage. 186: 245-255. PMID 30449729 DOI: 10.1016/J.Neuroimage.2018.10.061  0.656
2018 Romano S, Salles A, Amalric M, Dehaene S, Sigman M, Figueira S. Bayesian validation of grammar productions for the language of thought. Plos One. 13: e0200420. PMID 29990351 DOI: 10.1371/Journal.Pone.0200420  0.62
2017 Amalric M, Dehaene S. Cortical circuits for mathematical knowledge: evidence for a major subdivision within the brain's semantic networks. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 373. PMID 29292362 DOI: 10.1098/Rstb.2016.0515  0.585
2017 Amalric M, Denghien I, Dehaene S. On the role of visual experience in mathematical development: Evidence from blind mathematicians. Developmental Cognitive Neuroscience. PMID 29033221 DOI: 10.1016/J.Dcn.2017.09.007  0.521
2017 Amalric M, Wang L, Pica P, Figueira S, Sigman M, Dehaene S. The language of geometry: Fast comprehension of geometrical primitives and rules in human adults and preschoolers. Plos Computational Biology. 13: e1005273. PMID 28125595 DOI: 10.1371/Journal.Pcbi.1005273  0.675
2016 Amalric M, Dehaene S. Origins of the brain networks for advanced mathematics in expert mathematicians. Proceedings of the National Academy of Sciences of the United States of America. PMID 27071124 DOI: 10.1073/Pnas.1603205113  0.57
Low-probability matches (unlikely to be authored by this person)
2021 Hamami Y, Mumma J, Amalric M. Counterexample Search in Diagram-Based Geometric Reasoning. Cognitive Science. 45: e12959. PMID 33873252 DOI: 10.1111/cogs.12959  0.292
2011 Moussa R, Poucet B, Amalric M, Sargolini F. Contributions of dorsal striatal subregions to spatial alternation behavior. Learning & Memory (Cold Spring Harbor, N.Y.). 18: 444-51. PMID 21685151 DOI: 10.1101/Lm.2123811  0.187
1998 Baunez C, Salin P, Nieoullon A, Amalric M. Impaired performance in a conditioned reaction time task after thermocoagulatory lesions of the fronto-parietal cortex in rats. Cerebral Cortex (New York, N.Y. : 1991). 8: 301-9. PMID 9651127 DOI: 10.1093/Cercor/8.4.301  0.186
2007 De Leonibus E, Pascucci T, Lopez S, Oliverio A, Amalric M, Mele A. Spatial deficits in a mouse model of Parkinson disease. Psychopharmacology. 194: 517-25. PMID 17619858 DOI: 10.1007/S00213-007-0862-4  0.179
1986 Swerdlow NR, Vaccarino FJ, Amalric M, Koob GF. The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacology, Biochemistry, and Behavior. 25: 233-48. PMID 2875470 DOI: 10.1016/0091-3057(86)90261-3  0.168
2005 Courtière A, Hardouin J, Locatelli V, Turle-Lorenzo N, Amalric M, Vidal F, Hasbroucq T. Selective effects of partial striatal 6-OHDA lesions on information processing in the rat. The European Journal of Neuroscience. 21: 1973-83. PMID 15869490 DOI: 10.1111/j.1460-9568.2005.04015.x  0.135
2003 Risterucci C, Terramorsi D, Nieoullon A, Amalric M. Excitotoxic lesions of the prelimbic-infralimbic areas of the rodent prefrontal cortex disrupt motor preparatory processes. The European Journal of Neuroscience. 17: 1498-508. PMID 12713653 DOI: 10.1046/J.1460-9568.2003.02541.X  0.132
2003 Darbaky Y, Forni C, Amalric M, Baunez C. High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task. The European Journal of Neuroscience. 18: 951-6. PMID 12925021 DOI: 10.1046/J.1460-9568.2003.02803.X  0.118
2009 De Leonibus E, Managò F, Giordani F, Petrosino F, Lopez S, Oliverio A, Amalric M, Mele A. Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 729-38. PMID 18704096 DOI: 10.1038/Npp.2008.129  0.114
1975 Amalric MP. [Retinoangiography with the wide-angle retinograph]. Bulletin Des SociéTéS D'Ophtalmologie De France. 75: 181-4. PMID 1204157  0.113
1989 Amalric M, Koob GF. Dorsal pallidum as a functional motor output of the corpus striatum. Brain Research. 483: 389-94. PMID 2706530 DOI: 10.1016/0006-8993(89)90186-8  0.111
1993 Amalric M, Koob GF. Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. Progress in Brain Research. 99: 209-26. PMID 8108549 DOI: 10.1016/S0079-6123(08)61348-5  0.111
1995 Amalric M, Moukhles H, Nieoullon A, Daszuta A. Complex deficits on reaction time performance following bilateral intrastriatal 6-OHDA infusion in the rat. The European Journal of Neuroscience. 7: 972-80. PMID 7613632 DOI: 10.1111/J.1460-9568.1995.Tb01085.X  0.111
2006 Risterucci C, Coccurello R, Banasr M, Stutzmann JM, Amalric M, Nieoullon A. The metabotropic glutamate receptor subtype 5 antagonist MPEP and the Na+ channel blocker riluzole show different neuroprotective profiles in reversing behavioral deficits induced by excitotoxic prefrontal cortex lesions. Neuroscience. 137: 211-20. PMID 16242848 DOI: 10.1016/J.Neuroscience.2005.08.054  0.106
2014 Chen L, Deltheil T, Turle-Lorenzo N, Liberge M, Rosier C, Watabe I, Sreng L, Amalric M, Mourre C. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1295-306. PMID 24661728 DOI: 10.1017/S1461145714000236  0.105
1995 Baunez C, Nieoullon A, Amalric M. Dopamine and complex sensorimotor integration: further studies in a conditioned motor task in the rat. Neuroscience. 65: 375-84. PMID 7777155 DOI: 10.1016/0306-4522(94)00498-T  0.105
1995 Baunez C, Nieoullon A, Amalric M. In a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 6531-41. PMID 7472415 DOI: 10.1523/Jneurosci.15-10-06531.1995  0.104
2002 Nieoullon A, Amalric M. [Brain dopamine receptors: molecular aspects and functional implications] Revue Neurologique. 158: 59-68. PMID 12690316  0.104
2011 Courtière A, Hardouin J, Burle B, Vidal F, Turle-Lorenzo N, Amalric M, Hasbroucq T. Dynamics of executive control and motor deficits in parkinsonian rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 11929-33. PMID 21849553 DOI: 10.1523/JNEUROSCI.2550-11.2011  0.103
2005 Oueslati A, Breysse N, Amalric M, Kerkerian-Le Goff L, Salin P. Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism. The European Journal of Neuroscience. 22: 2765-74. PMID 16324110 DOI: 10.1111/J.1460-9568.2005.04498.X  0.098
2002 Nieoullon A, Amalric M. [Dopaminergic receptors: structural features and functional implications]. Revue Neurologique. 158: S59-68. PMID 12690665  0.098
2015 Aidi-Knani S, Regaya I, Amalric M, Mourre C. Kv4 channel blockade reduces motor and neuropsychiatric symptoms in rodent models of Parkinson's disease. Behavioural Pharmacology. 26: 91-100. PMID 25356731 DOI: 10.1097/FBP.0000000000000107  0.097
2002 Smith AD, Amalric M, Koob GF, Zigmond MJ. Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 756-64. PMID 12007746 DOI: 10.1016/S0893-133X(01)00420-1  0.097
1994 Moukhles H, Amalric M, Nieoullon A, Daszuta A. Behavioural recovery of rats grafted with dopamine cells after partial striatal dopaminergic depletion in a conditioned reaction-time task. Neuroscience. 63: 73-84. PMID 7898663 DOI: 10.1016/0306-4522(94)90008-6  0.096
1993 Amalric M, Berhow M, Polis I, Koob GF. Selective effects of low-dose D2 dopamine receptor antagonism in a reaction-time task in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 8: 195-200. PMID 8507347 DOI: 10.1038/npp.1993.21  0.094
2014 Révy D, Jaouen F, Salin P, Melon C, Chabbert D, Tafi E, Concetta L, Langa F, Amalric M, Kerkerian-Le Goff L, Marie H, Beurrier C. Cellular and behavioral outcomes of dorsal striatonigral neuron ablation: new insights into striatal functions. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2662-72. PMID 24903652 DOI: 10.1038/npp.2014.121  0.093
2015 Maurice N, Liberge M, Jaouen F, Ztaou S, Hanini M, Camon J, Deisseroth K, Amalric M, Kerkerian-Le Goff L, Beurrier C. Striatal Cholinergic Interneurons Control Motor Behavior and Basal Ganglia Function in Experimental Parkinsonism. Cell Reports. 13: 657-66. PMID 26489458 DOI: 10.1016/j.celrep.2015.09.034  0.092
1986 Amalric M, Blasco TA, Smith NT, Lee DE, Swerdlow NR, Koob GF. 'Catatonia' produced by alfentanil is reversed by methylnaloxonium microinjections into the brain. Brain Research. 386: 287-95. PMID 3022882 DOI: 10.1016/0006-8993(86)90165-4  0.091
1994 Baunez C, Nieoullon A, Amalric M. N-methyl-D-aspartate receptor blockade impairs behavioural performance of rats in a reaction time task: new evidence for glutamatergic-dopaminergic interactions in the striatum. Neuroscience. 61: 521-31. PMID 7969928 DOI: 10.1016/0306-4522(94)90431-6  0.09
1994 Amalric M, Ouagazzal A, Baunez C, Nieoullon A. Functional interactions between glutamate and dopamine in the rat striatum. Neurochemistry International. 25: 123-31. PMID 7994193 DOI: 10.1016/0197-0186(94)90031-0  0.09
1996 Baunez C, Amalric M. Evidence for functional differences between entopeduncular nucleus and substantia nigra: effects of APV (DL-2-amino-5-phosphonovaleric acid) microinfusion on reaction time performance in the rat. The European Journal of Neuroscience. 8: 1972-82. PMID 8921288 DOI: 10.1111/J.1460-9568.1996.Tb01341.X  0.089
1987 Amalric M, Koob GF. Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 7: 2129-34. PMID 3112323  0.089
2012 Lopez S, Jouve L, Turle-Lorenzo N, Kerkerian-Legoff L, Salin P, Amalric M. Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity. Neurobiology of Disease. 46: 69-77. PMID 22245662 DOI: 10.1016/j.nbd.2011.12.045  0.087
1991 Schmied A, Amalric M, Dormont JF, Farin D. GABAergic control of rubral single unit activity during a reaction time task. Experimental Brain Research. 84: 285-96. PMID 2065735 DOI: 10.1007/BF00231448  0.087
2015 Maurice N, Deltheil T, Melon C, Degos B, Mourre C, Amalric M, Kerkerian-Le Goff L. Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease. Plos One. 10: e0142838. PMID 26571268 DOI: 10.1371/journal.pone.0142838  0.086
2006 Turle-Lorenzo N, Maurin B, Puma C, Chezaubernard C, Morain P, Baunez C, Nieoullon A, Amalric M. The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. 319: 914-23. PMID 16920993 DOI: 10.1124/Jpet.106.109207  0.085
1995 Amalric M, Baunez C, Nieoullon A. Does the blockade of excitatory amino acid transmission in the basal ganglia simply reverse reaction time deficits induced by dopamine inactivation? Behavioural Pharmacology. 6: 508-519. PMID 11224358 DOI: 10.1097/00008877-199508000-00011  0.081
1991 Schmied A, Farin D, Amalric M, Dormont JF. Changes in motor performance and rubral single unit activity in cats after microinjections of serotonin into the red nucleus area. Brain Research. 567: 91-100. PMID 1815833 DOI: 10.1016/0006-8993(91)91440-C  0.077
1984 Amalric M, Conde H, Dormont JF, Farin D, Schmied A. Activity of caudate nucleus neurons in cat performing a reaction time task. Neuroscience Letters. 49: 253-8. PMID 6493607 DOI: 10.1016/0304-3940(84)90298-2  0.075
2002 Baunez C, Amalric M, Robbins TW. Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 562-8. PMID 11784803 DOI: 10.1523/Jneurosci.22-02-00562.2002  0.074
2009 Beurrier C, Lopez S, Révy D, Selvam C, Goudet C, Lhérondel M, Gubellini P, Kerkerian-LeGoff L, Acher F, Pin JP, Amalric M. Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 3619-28. PMID 19525404 DOI: 10.1096/fj.09-131789  0.073
2012 Goudet C, Vilar B, Courtiol T, Deltheil T, Bessiron T, Brabet I, Oueslati N, Rigault D, Bertrand HO, McLean H, Daniel H, Amalric M, Acher F, Pin JP. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 1682-93. PMID 22223752 DOI: 10.1096/Fj.11-195941  0.071
1983 Amalric M, Condé H, Dormont JF, Farin D, Schmied A. Cat red nucleus changes of activity during the motor initiation in a reaction time task. Experimental Brain Research. 52: 210-8. PMID 6641883 DOI: 10.1007/BF00236629  0.07
1990 Schmied A, Amalric M, Dormont JF, Farin D. GABAergic mechanisms in the cat red nucleus: effects of intracerebral microinjections of muscimol or bicuculline on a conditioned motor task. Experimental Brain Research. 81: 523-32. PMID 2226685 DOI: 10.1007/BF02423501  0.069
2012 Jones CK, Bubser M, Thompson AD, Dickerson JW, Turle-Lorenzo N, Amalric M, Blobaum AL, Bridges TM, Morrison RD, Jadhav S, Engers DW, Italiano K, Bode J, Daniels JS, Lindsley CW, et al. The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. 340: 404-21. PMID 22088953 DOI: 10.1124/Jpet.111.187443  0.067
2003 Breysse N, Amalric M, Salin P. Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 8302-9. PMID 12967992 DOI: 10.1523/Jneurosci.23-23-08302.2003  0.064
2013 Managò F, Lopez S, Oliverio A, Amalric M, Mele A, De Leonibus E. Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice. Psychopharmacology. 226: 541-50. PMID 23192313 DOI: 10.1007/S00213-012-2925-4  0.064
2007 Lopez S, Turle-Lorenzo N, Acher F, De Leonibus E, Mele A, Amalric M. Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 6701-11. PMID 17581957 DOI: 10.1523/Jneurosci.0299-07.2007  0.062
1995 Ouagazzal A, Amalric M. Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism. European Journal of Pharmacology. 294: 137-46. PMID 8788425  0.06
2002 Breysse N, Baunez C, Spooren W, Gasparini F, Amalric M. Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 5669-78. PMID 12097518 DOI: 10.1523/Jneurosci.22-13-05669.2002  0.06
1994 Cheruel F, Dormont JF, Amalric M, Schmied A, Farin D. The role of putamen and pallidum in motor initiation in the cat. I. Timing of movement-related single-unit activity. Experimental Brain Research. 100: 250-66. PMID 7813662 DOI: 10.1007/BF00227195  0.06
1997 Attarian S, Amalric M. Microinfusion of the metabotropic glutamate receptor agonist 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induces dopamine-dependent locomotor activation in the rat. The European Journal of Neuroscience. 9: 809-16. PMID 9153588  0.06
2010 Greco B, Lopez S, van der Putten H, Flor PJ, Amalric M. Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. 332: 1064-71. PMID 19940105 DOI: 10.1124/jpet.109.162115  0.06
2004 Coccurello R, Breysse N, Amalric M. Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1451-61. PMID 15039773 DOI: 10.1038/Sj.Npp.1300444  0.059
2005 Turle-Lorenzo N, Breysse N, Baunez C, Amalric M. Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease. Psychopharmacology. 179: 117-27. PMID 15726332 DOI: 10.1007/S00213-005-2202-X  0.058
2005 Baunez C, Dias C, Cador M, Amalric M. The subthalamic nucleus exerts opposite control on cocaine and 'natural' rewards. Nature Neuroscience. 8: 484-9. PMID 15793577 DOI: 10.1038/Nn1429  0.058
2015 Amalric M. Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease. Current Opinion in Pharmacology. 20: 29-34. PMID 25462289 DOI: 10.1016/j.coph.2014.11.001  0.057
1994 Kerkerian-Le Goff L, Amalric M, Nieoullon A. [Implication of neuroexcitatory amino acids in the anatomo- functional organization of the central gray nucleus: physio-pathological aspects]. Archives Internationales De Physiologie, De Biochimie Et De Biophysique. 102: A37-43. PMID 8000052  0.056
1999 Bartoli M, Ternaux JP, Forni C, Portalier P, Salin P, Amalric M, Monneron A. Down-regulation of striatin, a neuronal calmodulin-binding protein, impairs rat locomotor activity. Journal of Neurobiology. 40: 234-43. PMID 10413453 DOI: 10.1002/(Sici)1097-4695(199908)40:2<234::Aid-Neu9>3.0.Co;2-T  0.055
2003 Spooren W, Ballard T, Gasparini F, Amalric M, Mutel V, Schreiber R. Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders. Behavioural Pharmacology. 14: 257-77. PMID 12838033 DOI: 10.1097/01.fbp.0000081783.35927.8f  0.052
1986 Blasco TA, Lee D, Amalric M, Swerdlow NR, Smith NT, Koob GF. The role of the nucleus raphe pontis and the caudate nucleus in alfentanil rigidity in the rat. Brain Research. 386: 280-6. PMID 3096494 DOI: 10.1016/0006-8993(86)90164-2  0.052
1986 Amalric M, Koob GF, Creese I, Swerdlow NR. "Selective" D-1 and D-2 receptor antagonists fail to differentially alter supersensitive locomotor behavior in the rat. Life Sciences. 39: 1985-93. PMID 2946915 DOI: 10.1016/0024-3205(86)90322-X  0.051
1994 Ouagazzal A, Nieoullon A, Amalric M. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum. European Journal of Pharmacology. 251: 229-36. PMID 8149978 DOI: 10.1016/0014-2999(94)90404-9  0.051
1989 Dormont JF, Farin D, Schmied A, Amalric M. Cat red nucleus activity preceding movement depends on initiation conditions. Experimental Brain Research. 77: 271-82. PMID 2792275 DOI: 10.1007/BF00274984  0.051
1992 Amalric M, Heurteaux C, Nieoullon A, Lazdunski M. Behavioral effects of modulators of ATP-sensitive K+ channels in the rat dorsal pallidum. European Journal of Pharmacology. 217: 71-7. PMID 1356801 DOI: 10.1016/0014-2999(92)90513-4  0.05
1988 Schmied A, Amalric M, Dormont JF, Condé H, Farin D. Participation of the red nucleus in motor initiation: unit recording and cooling in cats. Behavioural Brain Research. 28: 207-16. PMID 3382513 DOI: 10.1016/0166-4328(88)90098-8  0.05
2007 Sibille P, Lopez S, Brabet I, Valenti O, Oueslati N, Gaven F, Goudet C, Bertrand HO, Neyton J, Marino MJ, Amalric M, Pin JP, Acher FC. Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists. Journal of Medicinal Chemistry. 50: 3585-95. PMID 17602546 DOI: 10.1021/Jm070262C  0.048
2008 Lopez S, Turle-Lorenzo N, Johnston TH, Brotchie JM, Schann S, Neuville P, Amalric M. Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats. Neuropharmacology. 55: 483-90. PMID 18625257 DOI: 10.1016/j.neuropharm.2008.06.038  0.048
1987 Swerdlow NR, Amalric M, Koob GF. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus. Pharmacology, Biochemistry, and Behavior. 26: 765-9. PMID 3110795 DOI: 10.1016/0091-3057(87)90609-5  0.047
2002 Breysse N, Risterucci C, Amalric M. D1 and D2 dopamine receptors contribute to the locomotor response induced by Group II mGluRs activation in the rat nucleus accumbens. Pharmacology, Biochemistry, and Behavior. 73: 347-57. PMID 12117589 DOI: 10.1016/S0091-3057(02)00851-1  0.044
1993 Ouagazzal A, Nieoullon A, Amalric M. Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats. Psychopharmacology. 111: 427-34. PMID 7870984 DOI: 10.1007/Bf02253532  0.042
1986 Vaccarino FJ, Amalric M, Swerdlow NR, Koob GF. Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat. Pharmacology, Biochemistry, and Behavior. 24: 61-5. PMID 3080760 DOI: 10.1016/0091-3057(86)90045-6  0.041
1994 Amalric M, Farin D, Dormont JF, Schmied A. GABA-receptor activation in the globus pallidus and entopeduncular nucleus: opposite effects on reaction time performance in the cat. Experimental Brain Research. 102: 244-58. PMID 7705503 DOI: 10.1007/BF00227512  0.04
2013 Amalric M, Lopez S, Goudet C, Fisone G, Battaglia G, Nicoletti F, Pin JP, Acher FC. Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease. Neuropharmacology. 66: 53-64. PMID 22664304 DOI: 10.1016/J.Neuropharm.2012.05.026  0.038
2000 Smith AD, Smith DL, Zigmond MJ, Amalric M, Koob GF. Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm. Psychopharmacology. 148: 355-60. PMID 10928307 DOI: 10.1007/s002130050063  0.036
1986 Koob GF, Vaccarino FJ, Amalric M, Bloom FE. Neurochemical substrates for opiate reinforcement. Nida Research Monograph. 71: 146-64. PMID 3025733  0.03
1985 Amalric M, Koob GF. Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat. Pharmacology, Biochemistry, and Behavior. 23: 411-5. PMID 4048236 DOI: 10.1016/0091-3057(85)90014-0  0.029
1987 Amalric M, Cline EJ, Martinez JL, Bloom FE, Koob GF. Rewarding properties of beta-endorphin as measured by conditioned place preference. Psychopharmacology. 91: 14-9. PMID 2950541 DOI: 10.1007/BF00690919  0.027
1973 Amalric MP. [Anterior ciliary vessel: arteries and veins]. Bulletin Des SociéTéS D'Ophtalmologie De France. 73: 81-6. PMID 4787589  0.013
1976 Amalric MP, Teulières J, Stanbuk M. [Fundus flavimaculatus modified suddenly by carotid arteriography]. Bulletin Des SociéTéS D'Ophtalmologie De France. 76: 125-8. PMID 1021312  0.01
1975 Amalric MP. [New perspectives in fluorescence angiography]. Bulletin Des SociéTéS D'Ophtalmologie De France. 75: 113-8. PMID 1204136  0.01
1973 Amalric MP. [Angiography and the argon laser]. Bulletin Des SociéTéS D'Ophtalmologie De France. 73: 265-76. PMID 4800066  0.01
1967 Amalric MP. [How can one avoid bad fluorescent angiographies?]. Bulletin Des SociéTéS D'Ophtalmologie De France. 67: 1107-13. PMID 5621630  0.01
Hide low-probability matches.